Moreover, IMD can reduce the levels of fasting blood glucose (FBG), insulin, free fatty acid, triglycerides, and total cholesterol, thereby improving metabolic syndromes like obesity and insulin resistance in T1DM rats, T2DM mice, hyperhomocysteinemia mice, and ApoE−/− atherosclerosis mice [39,40,41,42]. The gene discussed is APOE; the disease is hyperhomocysteinemia.